Anbarasu Kumaraswamy

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey W Tyner, Franziska Haderk, Anbarasu Kumaraswamy, Linda B Baughn, Brian Van Ness, Song Liu, Himangi Marathe, Joshi J Alumkal, Trever G Bivona, Keith Syson Chan, Brian J Druker, Alan D Hutson, Peter S Nelson, Charles L Sawyers, Christopher D Willey
Understanding Drug Sensitivity and Tackling Resistance in Cancer. Cancer research 82 (8) (2022)
Dae-Hwan Kim, Duanchen Sun, William K Storck, Katherine Welker Leng, Chelsea Jenkins, Daniel J Coleman, David Sampson, Xiangnan Guan, Anbarasu Kumaraswamy, Eva S Rodansky, Joshua A Urrutia, Jacob A Schwartzman, Chao Zhang, Himisha Beltran, Mark P Labrecque, Colm Morrissey, Jared M Lucas, Ilsa M Coleman, Peter S Nelson, Eva Corey, Samuel K Handelman, Jonathan Z Sexton, Rahul Aggarwal, Wassim Abida, Felix Y Feng, Eric J Small, Daniel E Spratt, Armand Bankhead, Arvind Rao, Emily M Gesner, Sarah Attwell, Sanjay Lakhotia, Eric Campeau, Joel A Yates, Zheng Xia, Joshi J Alumkal
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)

Anbarasu Kumaraswamy.css-eqlu8i{font-size:small;padding-left:4px;}